Ascension Via Christi has announced that they are participating in clinical trials for treating Covid-19 patients.
The Expanded Access to Convalescent Plasma for the Treatment of Patients with COVID-19 is being led by the Mayo Clinic. Infectious disease specialist Maggie Hagan, MD, is serving as the study’s principal investigator for Ascension Via Christi.
The study will involve using blood plasma from those who have recovered from Covid-19 and are carrying antibodies that can fight the disease. The plasma is then given to hospitalized patients who meet the study’s tight criteria to help them fight the disease.
“As a participating site, we will be looking at hospitalized patients being treated for COVID-19 to determine whether they meet the study’s criteria,” said Dr. Hagan in a news release. Hagan says the treatment could provide another option of treatment for severe or life-threatening cases of Covid-19.
Ascension Via Christi Hospital in Manhattan is participating in the same COVID-19 clinical trial. If you have recovered from Covid-19 and would like to donate your plasma for the clinical trial visit RedCrossBlood.org/Plasma4COVID.
